Prognostic effects of benidipine in patients with vasospastic angina: Comparison with diltiazem and amlodipine

Journal of Cardiovascular Pharmacology

Volumn 51, Issue 3, 2008, Pages 253-257

  Fukumoto, Yoshihiro ^a,b   Yasuda, Satoshi ^a   Ito, Akira ^b   Shimokawa, Hiroaki ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Benidipine; Calcium channel blockers; Coronary artery spasm; Prognosis

Indexed keywords

AMLODIPINE; BENIDIPINE; DILTIAZEM;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN INFARCTION; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY SPASM; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SMOKING; VARIANT ANGINA PECTORIS;

ADULT; AGED; AGED, 80 AND OVER; AMLODIPINE; ANGINA PECTORIS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY VASOSPASM; DIHYDROPYRIDINES; DILTIAZEM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 41349089387     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181624b05     Document Type: Article

References (25)

1. Mohri M, Shimokawa H, Takeshita A. Coronary artery spasm; Clinical aspects. In: Lanzer P, Topol EJ, Eds. Panvascular Medicine, Integrated Clinical Management. Heidelberg, Germany: Springer-Verlag; 2002:921-930.
2. Shimokawa H, Nagasawa K, Irie T, et al. Clinical characteristics and long-term prognosis of patients with variant angina. A comparative study between western and Japanese populations. Int J Cardiol. 1988;18:331-349.
3. Ito A, Fukumoto Y, Shimokawa H. Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers. J Cardiovasc Pharmacol. 2004;44:480-485.
4. Godfraind T. Calcium-channel modulators for cardiovascular disease. Expert Opin Emerg Drugs. 2006;11:49-73.
5. Maier-Lenz H, Rode H, Lenau H, et al. Benidipine hydrochloride a new calcium channel blocker of the dihydropyridine type. Pharmacokinetics, pharmacodynamics, tolerance and dose finding in mild to moderate hypertension. Arzneimittel-Forschung. 1988;38:1757-1763.
6. Chaffman M, Brogden RN. Diltiazem. A review of its pharmacological properties and therapeutic efficacy. Drugs. 1985;29:387-454.
7. Chahine RA, Feldman RL, Giles TD, et al. Efficacy and safety of amlodipine in vasospastic angina: an interim report of a multicenter, placebo-controlled trial. The Investigators of Study 160. Am Heart J. 1989;118:1128-1130.
8. Sakata K, Kudo M. Efficacy of benidipine hydrochloride on cardiac event in patients with vasospastic angina without significant coronary artery narrowing: Comparison with diltiazem by case control study. Ther Res. 2003;24:2093-2100.
9. Io K, Minatoguchi S, Nishigaki K, et al. Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Arzneimittel-Forschung. 2007;57:573-581.
10. Yao K, Ina Y, Nagashima K, et al. Antioxidant effects of calcium antagonists in rat brain homogenates. Biol Pharm Bull. 2000;23:766-769.
11. 2+ channel blocker, on expression of cytokine-induced adhesion molecules and chemoattractants in human aortic endothelial cells. Eur J Pharmacol. 2004;498:303-314.
12. Kita T, Suzuki Y, Eto T, et al. Long-term anti-hypertensive therapy with benidipine improves arterial stiffness over blood pressure lowering. Hypertens Res. 2005;28:959-964.
13. Yamashita T, Kawashima S, Ozaki M, et al. A calcium channel blocker, benidipine, inhibits intimal thickening in the carotid artery of mice by increasing nitric oxide production. J Hypertens. 2001;19:451-458.
14. Shimokawa H. Cellular and molecular mechanisms of coronary artery spasm. Lessons from animal models. Jpn Circ J. 2000;64:1-12.
15. Kugiyama K, Yasue H, Okumura K, et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation. 1996;94:266-721.
16. Kitakaze M, Node K, Minamino T, et al. A Ca channel blocker, benidipine, increases coronary blood flow and attenuates the severity of myocardial ischemia via NO-dependent mechanisms in dogs. J Am Coll Cardiol. 1999;33:242-249.
17. Kobayashi N, Kobayashi K, Hara K, et al. Benidipine stimulates nitric oxide synthase and improves coronary circulation in hypertensive rats. Am J Hypertens. 1999;12:483-491.
18. Suzuki H, Yokoyama K, Akimoto Y, et al. Clinical efficacy of benidipine for vasospastic angina pectoris. Arzneimittel-Forschung. 2007;57:20-25.
19. Karasawa A, Kubo K. Calcium antagonistic effects and the in vitro duration of actions of KW-3049, a new 1,4-dihydropyridine derivative, in isolated canine coronary arteries. Jpn J Pharmacol. 1988;47:35-44.
20. Moriyama T, Karasawa A. Cardiovascular effects of benidipine and amlodipine in isolated tissues and anesthetized dogs. Biol Pharm Bull. 1994;17:1468-1471.
21. Karasawa A, Kubo K, Shuto K, et al. Antianginal effects of the new calcium antagonist benidipine hydrochloride in anesthetized rats and spontaneously hypertensive rats. Electrocardiographic study. Arzneimittel-Forschung. 1988;38:702-707.
22. Zhang X, Hintze TH. Amlodipine releases nitric oxide from canine coronary microvessels. Circulation. 1998;97:576-580.
23. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Eng J Med. 2005;352:1293-1304.
24. Herlitz J, Holm J, Peterson M, et al. Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study. Eur Heart J. 2004;25:232-239.
25. Statistics Division, Statistics and Information Department, Ministry of Health, Labour and Welfare: Abridged life tables for Japan 2003. Tokyo: Health and Welfare Statistics Association; 2005.